Jiangsu Zhongbang Pharmaceutical Co Ltd

Jiangsu Zhongbang Pharmaceutical Co. Ltd. has been founded in 2001. As a high-tech enterprise, Zhongbang focuses on developing and producing pharmaceutical intermediates, APIs and finished products. The registered capital of Zhongbang is $1.26 billion and total area is 100,000 m2.

Zhongbang concentrates on the production technique of proton pump inhibitors “Prazole”, anti-hypertension “Sartan” and anticoagulants “Xaban” for more than 15 years.